DHR vs MA: Which Is the Better Buy?
Side-by-side comparison of Danaher Corporation and Mastercard Incorporated — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-06-20.
Danaher Corporation · Healthcare
$177.17
+8.9% upside to fair value
Grade B
High Quality
VS
Mastercard Incorporated · Financial Services
$489.79
+40.9% upside to fair value
Grade B
High Quality
QuantHub Verdict
MA has more upside to fair value
(+40.9%).
MA trades at a lower forward P/E
(28.3x).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
DHR |
MA |
| Current Price |
$177.17 |
$489.79 |
| Fair Value Estimate |
$192.90 |
$690.33 |
| Upside to Fair Value |
+8.9%
|
+40.9%
|
| Market Cap |
$125.4B |
$432.8B |
| Forward P/E |
34.1x
|
28.3x
|
| EV / EBITDA |
20.8x
|
20.9x
|
| Price / Sales |
5.1x
|
12.8x
|
| Price / FCF |
23.7x
|
24.4x
|
| Revenue Growth YoY |
+3.7%
|
+15.8%
|
| Gross Margin |
60.7%
|
83.0%
|
| Operating Margin |
21.0%
|
59.4%
|
| Return on Equity |
7.1%
|
206.1%
|
| Dividend Yield |
0% |
0% |
| FCF Yield |
4.22%
|
4.09%
|
| Analyst Consensus |
Strong Buy
|
Strong Buy
|
Investment Thesis
Danaher Corporation operates in the healthcare sector, specializing in medical diagnostics and research tools through three balanced platforms: Biotechnology, Life Sciences, and Diagnostics. The company benefits from a durable competitive moat supported by the Danaher Business System, disciplined capital allocation, and a platform-centric organizational structure. Despite modest revenue growth of…
Mastercard Incorporated operates a global payments network providing payment processing and value-added services. The company benefits from a durable competitive moat built on its global card-network scale, processing infrastructure, brand strength, and regulatory integrations. It commands a high return on equity of 206.1% and strong margins with a net margin of 45.9%. Revenue and earnings grew 1…
Accumulation Zones
| Metric |
DHR |
MA |
| Zone Low |
$144.68 |
$517.75 |
| Zone High |
$163.97 |
$586.78 |
| In Buy Zone? |
No
|
Yes
|